Blasts 10-19 Percent of Bone Marrow Nucleated Cells
1 clinical trials · Condition
◉ Watch Blasts 10-19 Percent of Bone Marrow Nucleated Cells
| Record | Firm | Date |
|---|---|---|
| CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT03896269) | M.D. Anderson Cancer Center | 2019-05-14 |
Track Blasts 10-19 Percent of Bone Marrow Nucleated Cells automatically
Every clearance here is in the API, with alerts when new ones post.